BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2865258)

  • 1. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
    Rich DH; Moon BJ; Harbeson S
    J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
    Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic and X-ray crystallographic characterization of bestatin bound to the aminopeptidase from Aeromonas (Vibrio) proteolytica.
    Stamper CC; Bienvenue DL; Bennett B; Ringe D; Petsko GA; Holz RC
    Biochemistry; 2004 Aug; 43(30):9620-8. PubMed ID: 15274616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-binding inhibition of the aminopeptidase from Aeromonas proteolytica by peptide thiols: synthesis and spectroscopic characterization.
    Huntington KM; Bienvenue DL; Wei Y; Bennett B; Holz RC; Pei D
    Biochemistry; 1999 Nov; 38(47):15587-96. PubMed ID: 10569943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aminopeptidases by aminophosphonates.
    Lejczak B; Kafarski P; Zygmunt J
    Biochemistry; 1989 Apr; 28(8):3549-55. PubMed ID: 2568128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state.
    Kim H; Lipscomb WN
    Biochemistry; 1993 Aug; 32(33):8465-78. PubMed ID: 8357796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N.
    Matsas R; Stephenson SL; Hryszko J; Kenny AJ; Turner AJ
    Biochem J; 1985 Oct; 231(2):445-9. PubMed ID: 2865952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecificity of amino acid hydroxamate inhibition of aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1983 Nov; 258(22):13517-21. PubMed ID: 6643439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase.
    Peppers SC; Lenney JF
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1281-6. PubMed ID: 3242551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells.
    Amoscato AA; Alexander JW; Babcock GF
    J Immunol; 1989 Feb; 142(4):1245-52. PubMed ID: 2915119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.
    Harbeson SL; Rich DH
    Biochemistry; 1988 Sep; 27(19):7301-10. PubMed ID: 3207677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin.
    Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE
    Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer.
    Suda H; Aoyagi T; Takeuchi T; Umezawa H
    Arch Biochem Biophys; 1976 Nov; 177(1):196-200. PubMed ID: 999285
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.
    Tieku S; Hooper NM
    Biochem Pharmacol; 1992 Nov; 44(9):1725-30. PubMed ID: 1360211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues.
    Ocain TD; Rich DH
    J Med Chem; 1988 Nov; 31(11):2193-9. PubMed ID: 3184126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
    Frick L; Wolfenden R
    Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.